Search press releases
Every release here is real and links to its original. Filter by company, topic, language and date.
- GoogleGoogle Fitbit Edge: Our all-new smartest fitness tracker everCompanies: Alphabet Inc.Pre-order our newest fitness tracker and get access to our most advanced health tools — plus, a week of battery life from a single charge.
- GoogleHow we’re making Google Health and Fitbit Air smarter than everCompanies: Alphabet Inc.Our most advanced wellness tools, premium metal bands, and deeper app partnerships bring everything you need directly to your wrist.
- GoogleWe’re partnering with Flo Health to elevate women’s healthCompanies: Alphabet Inc.Google Health announces new partnership and deeper commitment to women’s health with Flo Health.
- GoogleFrom game days to daily life: The familiar faces teaming up with Google HealthCompanies: Alphabet Inc.See the athletes, creators, and wellness experts who are using Google Health to help make our technology better for everyone.
- GoogleGoogle Health: Evolving so you can focus on living betterCompanies: Alphabet Inc.What’s new from Google Health: Explore the new Fitbit Edge, expanded workout tracking, and dedicated women's health insights.
- Vxtra HealthAnother Healthcare Increase Is Coming. Are Employers Watching the Spending Closely Enough?As 2027 benefit costs climb and workers absorb more of the expense, Vxtra Health founder Larry Hightower says employers need more timely visibility into the claims, contracts and pricing patterns driving their healthcare spending. ATLANTA, Oct. 12, 2026 -- Employers are...
- Palisade Bio Presents New Clinical, Pharmacokinetic, Pharmacodynamic and Mechanistic Data Strengthening the Phase 2 Rationale for PALI-2108 in Ulcerative Colitis and Crohn’s Disease at ACG 2026Five presentations connect targeted intestinal exposure and sustained systemic drug exposure with PDE4 target engagement and early clinical activity, supporting ongoing Phase 2 development
- Geron Corporation Presentations feature real-world experience and clinical evidence in lower-riskGeron Corporation Announces Oral Presentations Highlighting Imetelstat at International Hematology Congresses in Europe and AsiaPresentations feature real-world experience and clinical evidence in lower-risk MDS, underscoring growing global scientific engagement with imetelstat
- Bausch Health Companies Inc.Six-Month Pilot Study Demonstrates Improved Guideline Adherence Following Implementation of Standardized Cirrhosis Clinical PathwayBausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals ("Salix"), announced results from a multicenter pilot study evaluating a standardized clinical pathway for cirrhosis management...
- STERIS Expands Healthcare Consumables Offering with Definitive Agreement to Acquire Xodus Medical, a Specialty Surgical Products Business Focused on Patient and OR Staff SafetyCompanies: SterisSTERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that STERIS Corporation, a wholly owned subsidiary of the Company, has signed a definitive agreement to acquire Xodus Medical, Inc., a specialty surgical products business based in Pennsylvania, and certain related affiliates (“Xodus Medical”), for $2.1 billion at closing. STERIS anticipates that the transaction will generate cash tax benefits with a net present value of approximately $300 million, resulting in a net purchase price of approximately $1.8 billion. The purchase price is subject to customary adjustments, with additional potential earnout consideration of up to $150 million based on the achievement of specified post-closing performance targets in calendar 2028. Annual revenue of Xodus Medical in calendar 2026 is anticipated to be approximately $245 million, with adjusted EBIT of approximately $135 million.
- Dimensional Fund Advisors Ltd. : Form 8.3 - ADVANCED MEDICAL SOLUTIONS - Ordinary SharesFORM 8.3
- Global Clinical Contract Research Organization (CRO) Market - Strategic Forecast, 2026-2031 | Outsourcing and AI-Led Trials Fuel 7.9% CAGR to USD 130.9 Billion"Clinical CRO Market - Strategic Insights and Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's offering.